Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)
Clinical trial NCT04439344 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439344
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-31
- Primary completion
- 2019-05-03
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.